FGFR2-related craniosynostosis: genes and variants
Explore variant evidence for FGFR2-related craniosynostosis across 1 analyzed protein (FGFR2). Linked ClinVar records include 54 pathogenic or likely pathogenic variants, 164 variants of uncertain significance and 15 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to FGFR2-related craniosynostosis
FGFR2: Fibroblast growth factor receptor 2
Its fibroblast-growth-factor signaling regulates proliferation, differentiation, and developmental patterning across multiple tissues. Germline activating variants cause several craniosynostosis syndromes, while somatic mutations, amplification, or fusions can drive cancer.
54 ClinVar pathogenic / likely pathogenic and 179 uncertain variants in FGFR2 have source records linked to FGFR2-related craniosynostosis. Association strength is not clinical gene validity.
Where FGFR2-related craniosynostosis variants cluster
- FGFR2 Ig-like C2-type 3 (positions 256–358): 33 of 48 ClinVar pathogenic / likely pathogenic variants, 5.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to FGFR2-related craniosynostosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGFR2 C278F | 278 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 W290R | 290 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C342R | 342 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 D321A | 321 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 G338R | 338 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 G338E | 338 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y340H | 340 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y340C | 340 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C342G | 342 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C342W | 342 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C342F | 342 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C342S | 342 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 A344G | 344 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 S354F | 354 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 S354C | 354 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y105C | 105 | Ig-like C2-type 1 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Q289P | 289 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 F276V | 276 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y281C | 281 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 I288N | 288 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 A337P | 337 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 T341P | 341 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 L357S | 357 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 E565A | 565 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 S239F | 239 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★★) |
| FGFR2 T320A | 320 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 S351C | 351 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 A648T | 648 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 A109P | 109 | Ig-like C2-type 1 | Pathogenic / likely pathogenic (★★) |
| FGFR2 S239C | 239 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★★) |
| FGFR2 P253R | 253 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR2 S267P | 267 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 G271V | 271 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y375C | 375 | Extracellular | Pathogenic / likely pathogenic (★★) |
| FGFR2 R450G | 450 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| FGFR2 K526E | 526 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 N549H | 549 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 K641R | 641 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 K659N | 659 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 G663E | 663 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 R678G | 678 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| FGFR2 G182V | 182 | Ig-like C2-type 2 | Pathogenic / likely pathogenic (★★) |
| FGFR2 Y328C | 328 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★★) |
| FGFR2 C278W | 278 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 W290L | 290 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 D321V | 321 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 G338W | 338 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 A344P | 344 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 V270F | 270 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 K292E | 292 | Ig-like C2-type 3 | Pathogenic / likely pathogenic (★) |
| FGFR2 V359F | 359 | Extracellular | Pathogenic / likely pathogenic (★) |
| FGFR2 E565K | 565 | Protein kinase | Pathogenic / likely pathogenic (★) |
| FGFR2 S372C | 372 | Extracellular | Pathogenic / likely pathogenic (★) |
| FGFR2 A362S | 362 | Extracellular | Pathogenic / likely pathogenic (★) |
Which prediction tools work for FGFR2-related craniosynostosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 97 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 94 out of 100
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 91 out of 100
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 85 out of 100
- phyloP: 84 out of 100
- SpliceAI: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Crouzon disease also has ClinVar records linked to FGFR2 variants; they fall in the same places as the FGFR2-related craniosynostosis variants (22 pathogenic / likely pathogenic).
- Apert syndrome also has ClinVar records linked to FGFR2 variants; they fall in the same places as the FGFR2-related craniosynostosis variants (6 pathogenic / likely pathogenic).
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis also has ClinVar records linked to FGFR2 variants; they fall in the same places as the FGFR2-related craniosynostosis variants (5 pathogenic / likely pathogenic).
- LADD syndrome also has ClinVar records linked to FGFR2 variants; they fall mostly in different places as the FGFR2-related craniosynostosis variants (5 pathogenic / likely pathogenic).
- Beare-Stevenson cutis gyrata syndrome also has ClinVar records linked to FGFR2 variants; they fall mostly in different places as the FGFR2-related craniosynostosis variants (3 pathogenic / likely pathogenic).
Diseases related to FGFR2-related craniosynostosis
- Pfeiffer syndrome, also linked to FGFR2
- Crouzon disease, also linked to FGFR2
- Colorectal cancer, also linked to FGFR2
- Gastric cancer, also linked to FGFR2
- Bilateral sensorineural hearing impairment, also linked to FGFR2
- Jackson-Weiss syndrome, also linked to FGFR2
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, also linked to FGFR2
- Apert syndrome, also linked to FGFR2
- Common craniosynostosis syndromes, also linked to FGFR2
- LADD syndrome, also linked to FGFR2
- Saethre-Chotzen syndrome, also linked to FGFR2
- Beare-Stevenson cutis gyrata syndrome, also linked to FGFR2
Frequently asked questions
Which genes have records linked to FGFR2-related craniosynostosis?
This view contains 1 analyzed proteins: FGFR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 54 pathogenic or likely pathogenic variants, 164 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 242 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center